UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention

Journal of the American College of Cardiology, 2017-02, Vol.69 (8), p.911-921

2017

Link zum Volltext

Verfügbarkeit prüfen

Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician

Circulation (New York, N.Y.), 2019-12, Vol.140 (24), p.2019-2037

2019

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory and Cholesterol Risk in the FOURIER Trial

Circulation (New York, N.Y.), 2018-07, Vol.138 (2), p.131-140

2018

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies

JACC. Basic to translational science, 2020-05, Vol.5 (5), p.518-536

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

Circulation (New York, N.Y.), 2016-07, Vol.134 (1), p.24-36

2016

Link zum Volltext

Verfügbarkeit prüfen

A current review of COVID-19 for the cardiovascular specialist

The American heart journal, 2020-08, Vol.226, p.29-44

2020

Link zum Volltext

Verfügbarkeit prüfen

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT

Circulation (New York, N.Y.), 2015-09, Vol.132 (13), p.1224-1233

2015

Link zum Volltext

Verfügbarkeit prüfen

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Stroke (1970), 2020-05, Vol.51 (5), p.1546-1554

2020

Link zum Volltext

Verfügbarkeit prüfen

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial

Journal of the American College of Cardiology, 2016-02, Vol.67 (4), p.353-361

2016

Link zum Volltext

Verfügbarkeit prüfen

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Circulation (New York, N.Y.), 2018-04, Vol.137 (15), p.1571-1582

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT

Circulation (New York, N.Y.), 2017-12, Vol.136 (25), p.2440-2450

2017

Link zum Volltext

Verfügbarkeit prüfen

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

Circulation (New York, N.Y.), 2016-07, Vol.134 (4), p.304-313

2016

Link zum Volltext

Verfügbarkeit prüfen

Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel

Journal of the American College of Cardiology, 2020-09, Vol.76 (11), p.1345-1357

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2020-12, Vol.142 (22), p.e379-e406

2020

Link zum Volltext

Verfügbarkeit prüfen

Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry

The American heart journal, 2023-04, Vol.258, p.149-156

2023

Link zum Volltext

Verfügbarkeit prüfen

The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial

European heart journal, 2016-12, Vol.37 (48), p.3576-3584

2016

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week

Journal of the American College of Cardiology, 2020-07, Vol.76 (1), p.72-84

2020

Link zum Volltext

Verfügbarkeit prüfen

The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry

Critical care medicine, 2021-08, Vol.49 (8), p.1293

2021

Link zum Volltext

Verfügbarkeit prüfen

The Nexus of Heart Failure and Critical Care Cardiology

Journal of cardiac failure, 2021-10, Vol.27 (10), p.1041-1041

2021

Link zum Volltext

Verfügbarkeit prüfen

Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis

European heart journal, 2023-01, Vol.44 (4), p.293-300

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117

2018

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial

Journal of the American College of Cardiology, 2019-08, Vol.74 (8), p.1057-1068

2019

Link zum Volltext

Verfügbarkeit prüfen

Research Priorities in Critical Care Cardiology: JACC Expert Panel

Journal of the American College of Cardiology, 2023-12, Vol.82 (24), p.2329

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome

Clinical chemistry (Baltimore, Md.), 2014-01, Vol.60 (1), p.158-164

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(164)
Buchkapitel
(1)

Sprache

Englisch
(165)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention

Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician

Inflammatory and Cholesterol Risk in the FOURIER Trial

COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

A current review of COVID-19 for the cardiovascular specialist

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel

Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart Association

Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry

The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial

COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week

The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry

The Nexus of Heart Failure and Critical Care Cardiology

Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial

Research Priorities in Critical Care Cardiology: JACC Expert Panel

Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome

Suchergebnisse filtern